All Stories

  1. Gutflix ‘How to Develop Guidelines’ Series
  2. Clinical impact of double-faecal immunochemical testing following implementation into standard triage and investigation of primary care referrals in patients with lower gastrointestinal symptoms
  3. Risk factors and clinical consequences of interval cancers arising within faecal immunochemical testing-based colorectal cancer screening programme
  4. The Increased Early Onset Colorectal Cancer in South East Scotland Is Indicative of a Wider UK Problem
  5. Editorial April 2025: The protocolisation of evidence synthesis: The good, the bad and the ugly
  6. Editorial March 2025: Getting the guidelines we need
  7. What Constitutes a High‐Quality Guideline: Exploring Consumers' Views
  8. Look east for perianal fistula surgery
  9. Hearing what isn't said
  10. Diagnostic Performance of Faecal Immunochemical Testing (FIT) in Patients with Lynch Syndrome Scheduled for Colonoscopic Surveillance
  11. Colorectal cancer prevalence in faecal immunochemical test non-returners: potential for health inequality in symptomatic referral pathways
  12. Rainfall causing diverticulitis: A parable of data mining
  13. Quality of clinical guidelines: It matters as it impacts patient care
  14. The power of p
  15. Patients’ frailty and co-morbidities do not affect short-term mortality following emergency colorectal cancer surgery
  16. Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
  17. Oncological and clinical outcomes after conventional right hemicolectomy
  18. Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing
  19. European Society of Coloproctology guidance on the use of mesh in the pelvis in colorectal surgery
  20. Short‐term outcomes of a COVID‐adapted triage pathway for colorectal cancer detection
  21. Nurse-led telephone outreach for a COVID-adapted suspected colorectal cancer pathway
  22. Implementation of a risk mitigating COVID-adapted colorectal cancer pathway
  23. Posterior Tibial Nerve Stimulation for Faecal Incontinence
  24. Development of a customised data management system for a COVID-19-adapted colorectal cancer pathway
  25. The COVID‐19 pandemic: considerations for resuming normal colorectal services
  26. Healthcare apps: why have they not really taken off
  27. Risk mitigation for suspected colorectal cancer diagnostic pathway during COVID-19 pandemic
  28. Contemporary surgical practice in the management of anal fistula: results from an international survey
  29. Home parenteral nutrition and employment in patients with intestinal failure: Factors associated with return to employment
  30. The Renew® anal insert for passive faecal incontinence: a retrospective audit of our use of a novel device
  31. A review of the effect of faecal incontinence and constipation on sexual function
  32. Long-term outcome of laparoscopic rectopexy for full-thickness rectal prolapse
  33. Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review
  34. Mapping the current flow in sacral nerve stimulation using computational modelling.
  35. Regeneration of the oesophageal muscle layer from oesophagus acellular matrix scaffold using adipose-derived stem cells
  36. Assessment and management of patients with intestinal failure: a multidisciplinary approach
  37. Standardising assessment and documentation of pouchoscopy
  38. A meta-analysis comparing open anterior component separation with posterior component separation and transversus abdominis release in the repair of midline ventral hernias
  39. Hypoxia Enhances Differentiation of Adipose Tissue-Derived Stem Cells toward the Smooth Muscle Phenotype
  40. Combined Laparoscopic and Perineal Approach to Omental Interposition Repair of Complex Rectovaginal Fistula
  41. Current practice of continence advisors in managing faecal incontinence in the United Kingdom: results of an online survey
  42. The prevalence of chronic peri‐pouch sepsis in patients treated for antibiotic‐dependent or refractory primary idiopathic pouchitis
  43. Complex abdominal wall reconstruction in the setting of active infection and contamination: a systematic review of hernia and fistula recurrence rates
  44. Long-term outcome of sacral neuromodulation for chronic refractory constipation
  45. Major Complex Abdominal Wall Repair in Contaminated Fields with Use of a Non‐cross‐linked Biologic Mesh: A Dual‐Institutional Experience
  46. The role of the defaecating pouchogram in the assessment of evacuation difficulty after restorative proctocolectomy and pouch–anal anastomosis
  47. European Society of Coloproctology consensus on the surgical management of intestinal failure in adults
  48. Neuromodulation
  49. Sacral nerve stimulation for faecal incontinence and constipation: a European consensus statement
  50. Response to: consensus on ventral rectopexy: report of a panel of experts
  51. Outcome of Sacral Nerve Stimulation for Fecal Incontinence at 5 Years
  52. Patient Responses to Different Neuromodulatory Treatments
  53. Perianal injectable bulking agents as treatment for faecal incontinence in adults
  54. Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in patients with previous adenomas and/or genetic disposition
  55. Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing recurrence and metachronous colorectal carcinomas in patients previously treated for colorectal cancer
  56. The Problematic Sacral Neuromodulation
  57. Nonsteroidal anti-inflammatory drugs (NSAID) and aspirin for preventing colorectal adenomas and carcinomas in general population
  58. Sacral Nerve Stimulation for Fecal Incontinence
  59. Percutaneous tibial nerve stimulation for slow transit constipation: a pilot study
  60. Medium-Term Outcome of Sacral Nerve Modulation for Constipation
  61. Postoperative Issues of Sacral Nerve Stimulation for Fecal Incontinence and Constipation: A Systematic Literature Review and Treatment Guideline
  62. Long-term outcome of the use of botulinum toxin injection for functional anal pain
  63. Sacral Nerve Stimulation
  64. Gracilis muscle transposition for complex fistula and persistent nonhealing sinus in perianal Crohnʼs disease
  65. Faecal incontinence following radiotherapy for prostate cancer: A systematic review
  66. Suboptimal outcome following sacral nerve stimulation for faecal incontinence
  67. Temporary sacral nerve stimulation for faecal incontinence following pelvic radiotherapy
  68. Sacral Nerve Stimulation for Constipation: Suboptimal Outcome and Adverse Events
  69. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease
  70. Perianal injectable bulking agents as treatment for faecal incontinence in adults
  71. Predictors of the outcome of percutaneous nerve evaluation for faecal incontinence
  72. The role of pouch compliance measurement in the management of pouch dysfunction
  73. Retention Test in Sacral Nerve Stimulation for Fecal Incontinence
  74. Physiological, psychological and behavioural characteristics of men and women with faecal incontinence
  75. Perianal injectable bulking agents as treatment for faecal incontinence
  76. W1210 Clinical Outcome Measures of Response to Pharmacological Treatment in Perianal Crohn's Disease
  77. Open Hemorrhoidectomy
  78. Does the St. Mark's Incontinence Score Reflect Patients' Perceptions? A Review of 390 Patients
  79. Response to Smart et al.
  80. St. Mark's Incontinence Score
  81. Pilot study of two new injectable bulking agents for the treatment of faecal incontinence
  82. Long‐term results of perianal silicone injection for faecal incontinence
  83. Injectable Bulking Agents